EARNEST Partners
MYGN icon

EARNEST Partners’s Myriad Genetics MYGN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,977,292
Closed -$35.3M 294
2025
Q1
$35.3M Buy
3,977,292
+5,694
+0.1% +$50.5K 0.17% 158
2024
Q4
$54.5M Buy
3,971,598
+15,650
+0.4% +$215K 0.24% 140
2024
Q3
$108M Sell
3,955,948
-116,070
-3% -$3.18M 0.47% 84
2024
Q2
$99.6M Buy
4,072,018
+138,960
+4% +$3.4M 0.47% 87
2024
Q1
$83.9M Buy
3,933,058
+19,145
+0.5% +$408K 0.38% 101
2023
Q4
$74.9M Buy
3,913,913
+440,632
+13% +$8.43M 0.37% 109
2023
Q3
$55.7M Buy
3,473,281
+219,503
+7% +$3.52M 0.32% 121
2023
Q2
$75.4M Buy
3,253,778
+192,940
+6% +$4.47M 0.42% 103
2023
Q1
$71.1M Sell
3,060,838
-243,618
-7% -$5.66M 0.41% 103
2022
Q4
$47.9M Sell
3,304,456
-3,265,946
-50% -$47.4M 0.29% 124
2022
Q3
$125M Buy
6,570,402
+108,264
+2% +$2.07M 0.84% 34
2022
Q2
$117M Buy
6,462,138
+185,078
+3% +$3.36M 0.78% 42
2022
Q1
$158M Sell
6,277,060
-39,305
-0.6% -$990K 0.94% 27
2021
Q4
$174M Buy
6,316,365
+64,554
+1% +$1.78M 1.01% 28
2021
Q3
$202M Buy
6,251,811
+58,332
+0.9% +$1.88M 1.23% 17
2021
Q2
$189M Sell
6,193,479
-991,871
-14% -$30.3M 1.11% 24
2021
Q1
$219M Buy
7,185,350
+453,921
+7% +$13.8M 1.31% 14
2020
Q4
$133M Buy
6,731,429
+1,785,819
+36% +$35.3M 0.92% 35
2020
Q3
$64.5M Buy
4,945,610
+184,528
+4% +$2.41M 0.56% 76
2020
Q2
$54M Buy
4,761,082
+600,798
+14% +$6.81M 0.51% 86
2020
Q1
$59.5M Buy
4,160,284
+561,534
+16% +$8.04M 0.67% 58
2019
Q4
$98M Buy
3,598,750
+210,501
+6% +$5.73M 0.77% 51
2019
Q3
$97M Buy
+3,388,249
New +$97M 0.88% 39